Clinical Trial Update: Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia [Phase 3]

View source ↗

Summary

Phase 3 trial update examining abatacept for reversing subclinical inflammation measured by MRI in ACPA-positive arthralgia/arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthralgia
• Arthritis

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Arthralgia, Arthritis | Phase 3 | Status: COMPLETED